Saturday, 16 February 2019

Dental Consumables Market 2018 - Opportunity, Driving Trends and deep study 2023


Market Scenario:
Dental Consumables are a category of products that are used on patients by dental practitioners or dentists in order to treat and /or perform procedures associated with preventive, restorative, diagnostic and emergency oral health issues.
Dentistry is one of the oldest professions dating back to 7000 B.C. however it was not until the 1700s that it became a more defined profession.  Dental consumables industry has thus flourished as a result of the overall advances in the dentistry techniques adopted and practiced by dental professionals worldwide.
The various repairs and preventive cares associated with oral health of the ever growing population worldwide have consistently added to the growth of the dental consumables market globally. Dentistry as a branch has also further evolved and developed its sub branches resulting in specialist oral care depending upon the type of treatment required for the oral care. Major specializations include Endodontics, Orthodontics, Periodontics and Prosthodontics. Other specializations include professionals as Maxillofacial Surgeons, Pedodontist, Cosmetic/Aesthetic Dentist, and General Dentist. All these specializations more or less require the same kind of dental instruments, but most of their materials and other instruments may vary depending upon the treatment carried out.
Globally the market for Dental Consumables is growing steadily and has a bright future. The market for Dental Consumables is expected to grow at the CAGR of ~ 6.5% from 2016 to 2024.
Study Objectives of Dental Consumables Market:
  • To provide detailed analysis of the market structure along with forecast for the next 9 years of the various segments and sub-segments of the Dental Consumables market
  • To provide insights about factors affecting the market growth
  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
  • To provide country level analysis of the market with respect to the current market size and future prospective
  • To provide country level analysis of the market for segments by type and its sub-segments.
  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Dental Consumables market.
Intended Audience
  • Dental Consumables suppliers
  • Dental Consumables manufacturers
  • Dental Companies
  • Research and Development (R&D) Companies
  • Government Research Laboratories
  • Government and Independent Regulatory Authorities
  • Medical Research Institutes
Key Finding
  • The Dental Consumables global market is expected to reach $28,345 million by 2024.
  • Dental Implants segment holds the largest share of the market.
  • Europe holds the largest market share of Dental consumables market.
  • Globally, Asia-Pacific are expected to be fastest growing region and are anticipated to grow at the rate of ~7% during the forecast period.
Segments:                                                                                                                                        
Dental Consumables market has been segmented on the basis of types which comprises of Dental Implants, Dental Prosthetics, Dental Restorative Material, Dental Regenerative Material and Others.
Regional Analysis of Dental Consumables Market:                                               
Globally Europe is the largest market for Dental Consumables. North America is expected to be the second-largest market and furthermore Asia pacific market is expected to be the fastest growing market for Dental Consumables.
Key Players for Dental Consumables Market:
Some of the key players in this market are: Septodont, 3M, Straumann, Henry Schein, KERR Corporation, GC orthodontics, EnvisionTEC, Patterson Dental, American Orthodontics, Planmeca OY, Dentsply Sirona, Nobel Biocare (Part of danaher corporation)                                                                 
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Sepsis Diagnostics Market 2018 - Opportunity, Driving Trends and deep study 2023

This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Sepsis Diagnostics Market over the forecast period.
The global market for sepsis diagnostics is expected to reach USD 710 million by the end of the forecasted period and is expected to grow at a CAGR of 8%.
Market Scenario:
Sepsis is a type of life-threatening organ dysfunction arises when the body's response to an infection injures its own tissues and organs. It can be caused due to weakened immune system, chronic illness, kidney or liver disease, cancer and severe wounds. It can be of two types severe sepsis when there’s organ failure and other is septic shock in which there are the symptoms of severe sepsis includes a low blood pressure. The hospital-acquired infections and rising prevalence of sepsis has led to a growing need for its early diagnosis, which is one of the driving factor for sepsis diagnostics market.
Key Players for Global Sepsis Diagnostics Market:
Some of the key players in this market are: bioMérieux, Inc. (US), EKF Diagnostics (UK), Immunexpress (US), T2 Biosystems, Inc. (US), Becton, Dickinson and Company (US), Axis-Shield Diagnostics Ltd. (Scotland), Cube Dx GmbH (Austria), Sandstone Diagnostics, Inc. (US) and others.
Segments:
Global sepsis diagnostics market has been segmented on the basis of technology which comprises molecular diagnostics, biomarkers, immunoassays and others. On the basis of type of product product types; the market is segmented into kits, instruments, blood culture media and others. On the basis of end users the market is segmented into pathology laboratories, specialty clinics, hospitals, diagnostic centers and others.
Regional Analysis of Global Sepsis Diagnostics Market:
Globally North America is the largest market for medical tourism. The North American market for sepsis diagnostics is expected to reach USD 320 million by the end of the forecasted period.
Europe is the second largest market for sepsis diagnostics which is expected to grow at the CAGR of 6.8%. Asia Pacific is expected to be fastest growing region in sepsis diagnostics market.

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Latest Study Offers Detailed Insights on Injectable Drug Delivery Devices Market 2018

Global Injectable Drug Delivery Devices Market to capture a compound annual growth rate of 11.5% between 2018 and 2023.  A wide range of devices fall under the category of injectable drug delivery devices including conventional syringes, needle-free injectors, and auto and pen injectors. Demand for such devices has continued to increase in recent years as they are being used to treatment of medical conditions that witnessing a high prevalence rate. By the year 2023, the global injectable drug delivery devices market is set to surpass a valuation of USD 31,900 Mn.
 
Advances in design and technology are allowing their usage in more complex delivery procedures. Introduction of next-generation devices with superior functional capabilities is having a positive impact on the global injectable drug delivery devices market.  Others factor that can be linked with the market’s growth include increasing prevalence of chronic diseases, growing adoption of self-injectable devices, and rising FDA approvals.
Synopsis
This MRFR study includes a detailed analysis of the global injectable drug delivery devices market along with a five-year revenue projection that ends in 2023. As a part of market assessment, observation on different usage patterns (curative pattern and immunization), site of delivery (intramuscular, subcutaneous, intra dermal), product distribution channels (hospital & retail pharmacies and online platforms) and facility of use (hospitals and clinics and home care settings) is also made. The study also covers market dynamins such as drivers, trends, restrains and opportunities.
Companies Covered
Eisai Co., Ltd., Antares Pharma, AstraZeneca, Becton, Dickinson and Company, Eli Lilly and Company, F.Hoffmann-La Roche AG, Johnson & Johnson Services Inc., Mylan N.V., Novartis AG, Novo Nordisk, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., and Inovio Pharmaceuticals Inc.
The report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report.
Research Methodology
MRFR uses a set of cutting-edge research methods to provide consolidated reports rife with pertinent information and highly accurate assessments. Primary and secondary sources of information are carefully balanced for data authentication. Primary sources largely include interviews conducted with top-level executives. Meanwhile, secondary sources include authenticated databases, industry-specific journals, white papers, company annual reports and other public sources to ensure transparency. For market size estimation and validation, MRFR employs both top-down and bottom-up approaches for accuracy. All raw data is condensed into key data regarding the market and combined with pertinent observations from data analysts before report delivery.

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Precision Medicine Market 2018 Global– Key Players, Size, Trends, Growth- Analysis To 2023

Precision medicine refers to medicines developed as per an individual’s genetic profile that helps as a guide for the prevention, diagnosis and treatment of diseases. The global precision medicine market was valued at $38.92 billion in 2015, and is expected to reach $88.64 billion by 2022. Thus the market is expected to perform a growth at a CAGR of 12.48% from 2015 to 2022.
The major market driving factor for precision medicine are patient’s involvement in personal healthcare, integration of wireless technologies with portable healthcare devices, and increase in genetic diseases (due to mutation, UV rays) among others.


The market constraints include potential threat to personal data, high diagnostic cost as a barrier, potential risk of hardware or software failure, stringent regulations and standards, lack of awareness about the possible applications of precision medicine, reimbursement policies and regulatory framework, limited knowledge about the application of test and techniques, lack of research and evidences creating hindrances in its application.
Study Objectives Global Precision Medicine Market:
  • To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the global precision medicine market
  • To provide insights about factors affecting the market growth
  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
  • To provide country level analysis of the market with respect to the current market size and future prospective
  • To provide country level analysis of the market for segments by ecosystem (pharma & biotech companies, diagnostic tool companies, healthcare it/ big data companies, clinical laboratories), by sub-markets (companion diagnostics, biomarker-based test, targeted therapeutics, pharmacogenomics, molecular diagnostics, others), by therapeutics (cancer/oncology, cardiovascular disease, central nervous system, infectious diseases, others)
  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.
Key Players for Global Precision Medicine Market:Abbott Laboratories, Almac Group, Ltd., Asuragen, Inc., Biomérieux Sa, Cepheid Inc., Cetics Healthcare Technologies Gmbh, Ge Healthcare, Glaxosmithkline Plc, Johnson & Johnson, Laboratory Corporation Of America Holdings, Medtronic, Novartis, Pfizer Inc., Qiagen, Biobase Gmbh, Quest Diagnostics Inc, Randox Laboratories Ltd., Sanofi Pharma, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Ab-Biotics Sa, Caris Life Sciences, Healthcore, Inc., Ibm, Innventis, Intel Corporation, Molecular Health Gmbh, Precision For MedicineSegments:
Global Precision Medicine market has been segmented on the basis of ecosystem, sub-market, therapeutics and region.Regional Analysis of Global Precision Medicine Market:
Globally North America is the largest market for global precision medicine. Europe is the second-largest market for global precision medicine. The near future market for precision medicine will be dominated by the developed regions with developing regions providing a supporting role only. However the developing regions market particularly Asia Pacific will be the fastest growing and is likely to be the key to the future.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Microbiology Testing Market Trends and Drivers Analysis 2018 To 2023

Market Scenario:
Microbiology testing has emerged as one of the rapidly changing segment of healthcare over the past few years. Microbiology testing deals with the study of microbial germs and their clinical applications for the improvement of health. Increasing prevalence of various infectious diseases are driving the growth for global microbiology testing market.
Considering the global scenario of the Microbiology testing market, this market is one of the fastest growing market and expected to continue its growth near future. The total market for Microbiology testing was US$ 2706.1 million in 2016 and expected to reach US$ 5409.1 million by 2023. While considering the segments, Chemicals & Reagents was holding largest market share that was about 42.1% in 2016.
Segments:                                                                                                                                        
Global Microbiology testing Market has been segmented on the basis of type which comprise Instruments, Chemicals & Reagents, Consumables & Accessories, and others. On the basis of application, it is segmented into, Gastrointestinal Infections, Respiratory Infections, Urinary tract Infections, Sexually Transmitted Infections, Others. On the basis of end user, it is segmented into, Hospital based laboratory, Independent laboratory, and Academics & Research Institutes.
Regional Analysis of Global Microbiology testing Market:                  
Considering the global scenario of the market, North America was holding largest market share of 37.9% in global Microbiology testing market in 2016. Asia-Pacific is second largest and fastest growing market in global Microbiology testing market. APAC is expected to grow at a CAGR of 12.1% during 2017-2023. Europe was second largest microbiology testing market and is expected to grow at a significantly during the forecast period. On the other hand. Middle East and Africa (ME&A) microbiology testing market was growing lower than global average and expected to grow at steady pace. 
Key Players for Global Microbiology testing Market:                                 
Some of the key players in this market are: Alere (US), BD (US), Beckman Coulter, Inc. (US), Biomérieux SA (France), Cepheid (US), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (US)

The report for Global Microbiology testing Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Herbal Medicine Market 2018 - Opportunity, Driving Trends and deep study 2023

Market Snapshot
The Global Herbal Medicine Market continues to grow on account of the increasing popularity of herbal products in advanced economies. Europe has emerged as a major market for herbal medicines, which also characterizes the growing acceptance of the such products in the West. The outlook towards the herbal medicine industry remains positive for the medium term. The global herbal medicine market is expected to surge at a compound annual growth rate of 5.88% during the review period (2018-2023). Sales of herbal medicines is increasing at a healthy pace owing to consumer inclination towards such products. There is a growing preference for traditional and plant-based medicinal products across the globe.
Report Synopsis
This report offers a comprehensive assessment of the global herbal medicine market along with a five-year (2018-2023) revenue forecast. The report also includes a thorough discussion on factors impacting the future proposition of the market and its sub-markets. Revenue analysis on the basis of the different herbal medicine product is also available in the report. Various type of medical plants that are used for preparing herbal medicines in mentioned in the report. Further, primary forms of herbal medicine that are currently available has been discussed in the report. Other key pointers include medicine source, indication and distribution channel.
Companies Covered
Bayer AG, Arkopharma, Hishimo Pharmaceuticals, ZeinPharma Germany GmbH, Dasherb Corp, Blackmores, Dr. Willmar Schwabe India Pvt. Ltd., BEOVITA, Schaper & Brummer, Venus Pharma GmbH, Himalaya Global Holdings Ltd, and Arizona Natural Products.The report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report.
Research MethodologyMRFR employs a methodology that draws an extensive research that is of gold standard. The crux of the research exemplifies the best use of primary and secondary research techniques. For distilling raw data, a novel and tested data triangulation formula is utilized. This allows confirmation of information and data obtained through an exhaustive research. The research methodology is devised to deliver an unbiased market outlook. The multi-level evaluation process ensures a highly accuracy of the data and industry insights. Use of top-down and bottom-up approaches allow precise valuation of market and future projection.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

India CRO Market Anticipated To Witness Noteworthy Growth in the Coming Years


Market Scenario:
A contract research organization (CRO) provides support to the pharmaceutical, biotechnology, and medical device industries for specific services on a contract basis. The services may be clinical research, product development such as drug development or process development such as bio analytical assay development. A CRO may also provide management services such as clinical trials management, and pharmacovigilance. 
India is emerging as a top destination for contract research organizations for the following reasons
  • India’s acceptance of International guidelines and intellectual property rights
  • Presence of diverse types of climatic conditions thus allowing stability studies to be performed with ease in one destination
  • Educated and accessible human resource in India
  • Presence of diverse ethnic pool thus enabling diverse sample for clinical trials
  • Low operational cost due to cheap human resource
  • Availability of largest pool of patients and large hospitals
The other factors favoring the market are efforts by the regulatory authorities such as Director Controller General of India (DCGI), Indian Council of Medical Research (ICMR), Directorate General of Foreign Trade (DGFT), Department of Biotechnology (DBT) to create an amenable climate for research in India.
The market constraints are growing concern for security especially data security and patient security, lack of collaboration between universities and industry etc. The compromises done by some Indian CROs on ethical and technical standards are the greatest market threat.
Taking all factors into consideration, we expect the India CRO market to reach around $986.9 Million from $500 Million in 2017, by the end of the forecast period at a CAGR of ~12.00%.
Study Objectives India CRO Market:
  • To provide detail analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Indian CRO market
  • To provide insights about factors affecting the market growth
  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
  • To provide historical and forecast revenue of the market segments and sub-segments for India CRO market
  • To provide country level analysis of the market with respect to the current market size and future prospective
  • To provide country level analysis of the market for segments by service type, by therapeutic applications, by end users and other sub segments.
  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.


Key Players for India CRO Market:
Some of the key players in this market are: Quintiles IMS Holdings, Inc., Syngene, Pharmaceutical Product Development, LLC., Siro Clinpharm, Clininvent Research Pvt. Ltd., VIMTA, Bilcare Limited, Aizant Drug Research Solutions Private Limited, Piramal Pharma Solutions, Synapse Labs Pvt Limited, Eurofins Scientific, Laurus Labs., Neuland Laboratories Ltd, and PAREXEL International Corporation
Segments:
India CRO market has been segmented on the basis of service types which comprises clinical trials, product development, process development, post-marketing surveillance, quality monitoring and others. On the basis of therapeutic application; market is segmented into oncology, cardiovascular, neurology, nephrology and urology, and others. On the basis of end users; market is segmented into pharmaceutical/biopharmaceutical companies, medical devices companies and academic institutes.
Regional Analysis of India CRO Market:
The healthcare sector of India is divided between differential geographic regions and states. The South India and western India account for a major share of the Indian CRO market. However of late the CRO industry is shifting to the North. The reasons for this shift is the concentration of regulatory authority such as Director Controller General of India (DCGI) office, Indian Council of Medical Research (ICMR), Directorate General of Foreign Trade (DGFT), Department of Biotechnology (DBT) etc. Also the costs are lower in North India and the genetic pool is more diverse.Intended Audience
  • Contract Research Organizations
  • Medical Devices Suppliers
  • Private Research Laboratories
  • Research and Development (R&D) Companies
  • Market Research and Consulting Service Providers
  • Government Research Laboratories
  • Contract Manufacturing Organizations
The report for India CRO Market of Market Research Future comprises extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Subscribe to: Posts (Atom)